naproxen sodium
Generic: naproxen sodium
Labeler: target corporationDrug Facts
Product Profile
Brand Name
naproxen sodium
Generic Name
naproxen sodium
Labeler
target corporation
Dosage Form
TABLET
Routes
Active Ingredients
naproxen sodium 220 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
11673-764
Product ID
11673-764_46532fbb-e0e4-8e66-e063-6394a90a2a2a
Product Type
HUMAN OTC DRUG
Marketing Category
ANDA
Application Number
ANDA091353
Listing Expiration
2026-12-31
Marketing Start
2024-03-01
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
11673764
Hyphenated Format
11673-764
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
naproxen sodium (source: ndc)
Generic Name
naproxen sodium (source: ndc)
Application Number
ANDA091353 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 220 mg/1
Packaging
- 50 TABLET in 1 BOTTLE (11673-764-05)
- 90 TABLET in 1 BOTTLE (11673-764-09)
Packages (2)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "46532fbb-e0e4-8e66-e063-6394a90a2a2a", "openfda": {"unii": ["9TN87S3A3C"], "rxcui": ["849574"], "spl_set_id": ["fdb87abd-3176-dd62-e053-6394a90a6fcc"], "manufacturer_name": ["TARGET CORPORATION"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "50 TABLET in 1 BOTTLE (11673-764-05)", "package_ndc": "11673-764-05", "marketing_start_date": "20240301"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (11673-764-09)", "package_ndc": "11673-764-09", "marketing_start_date": "20240301"}], "brand_name": "Naproxen Sodium", "product_id": "11673-764_46532fbb-e0e4-8e66-e063-6394a90a2a2a", "dosage_form": "TABLET", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Nonsteroidal Anti-inflammatory Drug [EPC]"], "product_ndc": "11673-764", "generic_name": "Naproxen Sodium", "labeler_name": "TARGET CORPORATION", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Naproxen Sodium", "active_ingredients": [{"name": "NAPROXEN SODIUM", "strength": "220 mg/1"}], "application_number": "ANDA091353", "marketing_category": "ANDA", "marketing_start_date": "20240301", "listing_expiration_date": "20261231"}